James William Burns - 10 Feb 2023 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role: Chief Legal Officer
Signature: /s/ William Cook, as Attorney in Fact for James Burns
Issuer symbol: AGIO
Transactions as of: 10 Feb 2023
Net transactions value: -$18,287
Form type: 4
Filing time: 14 Feb 2023, 15:07:50 UTC
Previous filing: 28 Dec 2022
Next filing: 16 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGIO	Common stock	Options Exercise	$0	+1,834	+8.6%	$0.000000	23,052	10 Feb 2023	Direct
transaction	AGIO	Common stock	Tax liability	$18,287	-643	-2.8%	$28.44	22,409	14 Feb 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGIO	Restricted stock units	Options Exercise	$0	-1,834	-50%	$0.000000	1,833	10 Feb 2023	Common stock	1,834		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2	The restricted stock units were granted on February 10, 2021. Beginning on February 10, 2022, the shares underlying the restricted stock units will vest in three equal annual installments.